MarketCap
Facebook
X
TelegramАптеки 36.6 Bilanz 2004-2026 | APTK
Bilanz Jährlich Аптеки 36.6
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash And Cash Equivalents |
811 M | 1.73 B | 1 B | 847 M | 503 M | 659 M | 585 M | 284 M | 392 M | 489 M | 838 M | 889 M | 1.02 B | 738 M | 706 M | 808 M | 341 M | 226 M | 46.1 M |
Total Current Assets |
14.8 B | 13.5 B | 30.3 B | 14.2 B | 11.1 B | 15.8 B | 13.1 B | 9.26 B | 18.5 B | 2.66 B | 12.9 B | 13 B | 10.5 B | 8.89 B | 8.68 B | 8.9 B | 6.28 B | 3.43 B | 1.96 B |
Property Plant Equipment Net |
14.6 B | 10.9 B | 11.2 B | 8.5 B | 551 M | 781 M | 1.03 B | 1 B | 1.58 B | 1.02 B | 3.78 B | 3.3 B | 2.86 B | 3.01 B | 3.34 B | 4.61 B | 3.06 B | 2.43 B | 2.07 B |
Intangible Assets |
9.33 B | 9.28 B | 9.12 B | 6.26 B | 11.3 B | 22.9 B | 29.9 B | 16.3 B | 2.17 B | 17 M | 422 M | - | - | - | - | - | 219 M | - | - |
Goodwill And Intangible Assets |
13.5 B | 12.9 B | 12.5 B | 9.64 B | 14.7 B | 31.1 B | 39.5 B | 25.8 B | 11.7 B | 17 M | 5.3 B | 5.22 B | 5.19 B | 5.16 B | 5.25 B | 6.36 B | 4.49 B | 1.05 B | 690 M |
Long-Term Investments |
- | -560 M | 1.8 B | 945 M | 499 M | -8.13 B | 121 M | 145 M | -123 M | -567 M | 228 M | 224 M | - | - | - | - | - | - | - |
Tax Assets |
680 M | 560 M | -1.8 B | 248 M | 396 M | 431 M | 542 M | 357 M | 122 M | 100 M | 30 M | 94 M | - | - | - | - | - | - | - |
Total Non Current Assets |
28.8 B | 24.3 B | 24.1 B | 18.4 B | 21.7 B | 24.2 B | 31.6 B | 18.1 B | 14.1 B | 1.14 B | 9.33 B | 8.85 B | 8.27 B | 8.38 B | 8.62 B | 11 B | 7.55 B | 3.6 B | 2.77 B |
Total Assets |
43.6 B | 37.8 B | 54.4 B | 32.6 B | 32.7 B | 39.9 B | 44.8 B | 27.3 B | 32.6 B | 3.8 B | 22.2 B | 21.9 B | 18.8 B | 17.3 B | 17.3 B | 19.9 B | 13.8 B | 7.03 B | 4.73 B |
Account Payables |
14.6 B | 11 B | 8.07 B | 13.1 B | 11.3 B | 18.3 B | 21.5 B | 11 B | 17.4 B | 3.93 B | 5.89 B | 5.37 B | 3.31 B | 3.84 B | 6.07 B | 4.93 B | 2.95 B | 1.51 B | 819 M |
Short-Term Debt |
10.3 B | 15.9 B | 14.4 B | 10.9 B | 22.9 B | 3.82 B | 3.48 B | 796 M | 4.24 B | 2.12 B | 8.39 B | 8.42 B | 3.58 B | 2.82 B | 3.64 B | 6.71 B | 1.75 B | 800 M | 2.03 B |
Tax Payables |
903 M | 907 M | 883 M | 520 M | 5 M | 4 M | 1.03 B | 234 M | 469 M | 746 M | 378 M | 583 M | 436 M | 402 M | 636 M | 742 M | 291 M | - | - |
Deferred Revenue |
- | 2.26 B | 81 M | 87 M | 99 M | 67 M | 585 M | 234 M | 469 M | 746 M | 378 M | 583 M | 436 M | 402 M | 636 M | 742 M | - | - | - |
Total Current Liabilities |
27.5 B | 28.9 B | 24.6 B | 26.2 B | 36.8 B | 25.1 B | 27.9 B | 13.2 B | 24 B | 7.95 B | 15.8 B | 15.8 B | 7.98 B | 7.93 B | 11.4 B | 13.7 B | 5.22 B | 2.65 B | 3.07 B |
Long-Term Debt |
22.2 B | 15.4 B | 35.3 B | 29.7 B | 32.3 B | 28.4 B | 17.1 B | 12.3 B | 7.75 B | 6.42 B | 2.52 B | 1.57 B | 5.77 B | 4.65 B | 799 M | 530 M | 4.91 B | 2.36 B | 200 M |
Deferred Revenue Non Current |
- | -165 M | -221 M | -203 M | 4.9 B | -248 M | -269 M | -1 M | -519 M | -142 M | - | - | - | - | 1 | 1 | - | - | - |
Deferred Tax Liabilities Non Current |
347 M | 165 M | 221 M | 203 M | 347 M | 248 M | 269 M | 420 M | 519 M | 60 M | 207 M | 247 M | 193 M | 148 M | 138 M | 83.5 M | 214 M | 206 M | 231 M |
Total Non Current Liabilities |
22.5 B | 15.6 B | 35.6 B | 30 B | 32.7 B | 28.6 B | 17.4 B | 12.7 B | 8.27 B | 6.48 B | 2.73 B | 1.82 B | 5.98 B | 4.85 B | 942 M | 637 M | 5.13 B | 2.56 B | 430 M |
Total Liabilities |
50 B | 44.5 B | 60.1 B | 56.2 B | 69.5 B | 53.7 B | 45.3 B | 25.9 B | 32.3 B | 14.4 B | 18.6 B | 17.7 B | 14 B | 12.8 B | 12.4 B | 14.3 B | 10.3 B | 5.22 B | 3.5 B |
Retained Earnings |
-55.9 B | -56.1 B | -55.2 B | -61.5 B | -52.7 B | -29.7 B | -16.6 B | -7.24 B | -6.98 B | -17 B | -6.48 B | -5.5 B | -4.17 B | -3.17 B | -3.32 B | -1.37 B | 1.72 B | 955 M | 721 M |
Accumulated Other Comprehensive Income Loss |
- | - | - | - | -676 M | -586 M | -415 M | -184 M | -94 M | -2.06 B | -3.37 B | - | - | - | - | - | 244 M | - | - |
Total Stockholders Equity |
-6.43 B | -6.65 B | -5.7 B | -23.6 B | -36.8 B | -13.8 B | -531 M | 1.39 B | -740 M | -10.7 B | 214 M | 1.2 B | 2.16 B | 2.18 B | 262 M | 1.86 B | 2.33 B | 1.39 B | 1.16 B |
Total Liabilities And Stockholders Equity |
43.6 B | 37.8 B | 54.4 B | 32.6 B | 32.7 B | 39.9 B | 44.8 B | 27.3 B | 32.6 B | 3.8 B | 22.2 B | 21.9 B | 18.8 B | 17.3 B | 17.3 B | 19.9 B | 13.8 B | 7.03 B | 4.73 B |
Total Investments |
-680 M | -560 M | 384 M | 945 M | 499 M | -8.13 B | 121 M | 145 M | -123 M | -567 M | 228 M | 280 M | - | - | - | - | - | - | - |
Total Debt |
32.4 B | 31.3 B | 49.7 B | 40.6 B | 55.2 B | 32.2 B | 20.3 B | 13.2 B | 12.5 B | 8.55 B | 10.9 B | 9.57 B | 12.7 B | 7.47 B | 4.46 B | 7.24 B | 6.66 B | 3.16 B | 2.23 B |
Net Debt |
31.6 B | 29.6 B | 48.7 B | 39.8 B | 54.7 B | 31.5 B | 19.7 B | 12.9 B | 12.1 B | 8.06 B | 10.1 B | 8.68 B | 11.6 B | 6.74 B | 3.75 B | 6.43 B | 6.32 B | 2.93 B | 2.18 B |
Alle Zahlen in RUB-Währung
Bilanz Vierteljährlich Аптеки 36.6
| 2023-Q2 | 2022-Q4 | 2021-Q4 | 2021-Q2 | 2020-Q4 | 2020-Q2 | 2019-Q4 | 2019-Q2 | 2018-Q4 | 2018-Q2 | 2017-Q4 | 2017-Q2 | 2016-Q4 | 2016-Q2 | 2015-Q4 | 2015-Q2 | 2014-Q4 | 2014-Q2 | 2013-Q4 | 2013-Q2 | 2012-Q4 | 2012-Q2 | 2011-Q4 | 2010-Q4 | 2010-Q2 | 2009-Q4 | 2009-Q2 | 2008-Q4 | 2008-Q2 | 2007-Q4 | 2007-Q2 | 2006-Q4 | 2006-Q2 | 2005-Q4 | 2005-Q2 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash And Cash Equivalents |
521 M | 811 M | 1.73 B | 1.66 B | 1 B | 1.14 B | 847 M | 420 M | 503 M | 714 M | 659 M | 316 M | 585 M | 297 M | 284 M | 728 M | 392 M | 222 M | 489 M | 719 M | 838 M | 596 M | 889 M | 1.02 B | 879 M | 738 M | 722 M | 706 M | 757 M | 808 M | 575 M | 341 M | 284 M | 226 M | 136 M |
Total Current Assets |
13.4 B | 14.8 B | 13.5 B | 10.6 B | 30.3 B | 16.2 B | 14.2 B | 12.3 B | 11.1 B | 14.1 B | 15.8 B | 14.1 B | 13.1 B | 26.4 B | 9.26 B | 12.1 B | 18.5 B | 2.61 B | 2.66 B | 11.8 B | 12.9 B | 13.7 B | 13 B | 10.5 B | 9.7 B | 8.89 B | 8.79 B | 8.68 B | 8.79 B | 8.9 B | 7.59 B | 6.28 B | 4.86 B | 3.43 B | 2.7 B |
Property Plant Equipment Net |
15.4 B | 14.6 B | 10.9 B | 11.1 B | 11.2 B | 9.45 B | 8.5 B | 9.4 B | 9.93 B | 808 M | 773 M | 967 M | 1.03 B | 1.17 B | 1 B | 1.34 B | 1.58 B | 764 M | 964 M | 4.81 B | 3.78 B | 3.46 B | 3.3 B | 2.86 B | 2.93 B | 3.01 B | 3.17 B | 3.34 B | 3.97 B | 4.61 B | 3.83 B | 3.06 B | 2.75 B | 2.43 B | 2.25 B |
Intangible Assets |
9.11 B | 9.33 B | 9.28 B | 8.86 B | 9.12 B | 6.14 B | 6.26 B | 7.79 B | 7.96 B | 14 B | 14.8 B | 19.9 B | 20.4 B | 7.1 B | 6.75 B | 5.32 B | 2.17 B | 11 M | 16 M | 810 M | 422 M | - | - | - | - | - | - | - | - | - | 109 M | 219 M | 109 M | - | - |
Goodwill And Intangible Assets |
13.3 B | 13.5 B | 12.9 B | 12.2 B | 12.5 B | 9.53 B | 9.64 B | 11.2 B | 11.3 B | 22.1 B | 22.9 B | 29.4 B | 29.9 B | 16.6 B | 16.3 B | 14.8 B | 11.7 B | 11 M | 16 M | 5.69 B | 5.3 B | 5.23 B | 5.22 B | 5.19 B | 5.18 B | 5.16 B | 5.2 B | 5.25 B | 5.8 B | 6.36 B | 5.42 B | 4.49 B | 2.77 B | 1.05 B | 869 M |
Long-Term Investments |
- | - | - | 496 M | 1.8 B | 358 M | 945 M | -522 M | -28 M | - | - | - | - | 135 M | 145 M | - | - | -92 M | - | - | 228 M | - | 224 M | - | - | - | - | - | - | - | - | - | - | - | - |
Tax Assets |
680 M | 680 M | 560 M | -496 M | -1.8 B | 81 M | 248 M | 522 M | 396 M | 386 M | 431 M | 382 M | 542 M | 583 M | 357 M | 130 M | 122 M | 92 M | - | - | 30 M | - | 94 M | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Assets |
29.3 B | 28.8 B | 24.3 B | 23.8 B | 24.1 B | 19.6 B | 18.4 B | 21.1 B | 21.7 B | 23.3 B | 24.2 B | 30.9 B | 31.6 B | 18.6 B | 18.1 B | 16.6 B | 14.1 B | 867 M | 1.55 B | 10.5 B | 9.33 B | 8.94 B | 8.85 B | 8.27 B | 8.32 B | 8.38 B | 8.5 B | 8.62 B | 9.82 B | 11 B | 9.28 B | 7.55 B | 5.57 B | 3.6 B | 3.18 B |
Total Assets |
42.7 B | 43.6 B | 37.8 B | 34.4 B | 54.4 B | 35.8 B | 32.6 B | 33.4 B | 32.7 B | 37.4 B | 39.9 B | 45 B | 44.8 B | 45 B | 27.3 B | 28.7 B | 32.6 B | 3.48 B | 4.21 B | 22.3 B | 22.2 B | 22.7 B | 21.9 B | 18.8 B | 18 B | 17.3 B | 17.3 B | 17.3 B | 18.6 B | 19.9 B | 16.9 B | 13.8 B | 10.4 B | 7.03 B | 5.88 B |
Account Payables |
13.2 B | 14.6 B | 10.6 B | 7.68 B | 8.07 B | 8.67 B | 13.8 B | 10.4 B | 11.3 B | 12.6 B | 18.3 B | 15.6 B | 21.5 B | 23 B | 11 B | 12.2 B | 17.4 B | 3.03 B | 4.43 B | 5.99 B | 5.89 B | 6.92 B | 5.37 B | 3.31 B | 3.58 B | 3.84 B | 4.95 B | 6.07 B | 5.5 B | 4.93 B | 3.94 B | 2.95 B | 2.23 B | 1.51 B | 1.17 B |
Short-Term Debt |
10.1 B | 10.3 B | 15.9 B | 5.07 B | 14.4 B | 10.3 B | 10.9 B | 13.8 B | 22.9 B | 11.2 B | 3.82 B | 3.97 B | 3.48 B | 671 M | 892 M | 1.58 B | 3.65 B | 1.8 B | 2.12 B | 6.81 B | 8.39 B | 7.79 B | 8.42 B | 3.58 B | 3.2 B | 2.82 B | 3.23 B | 3.64 B | 5.17 B | 6.71 B | 4.23 B | 1.75 B | 1.27 B | 800 M | 1.41 B |
Tax Payables |
1.03 B | 903 M | 907 M | 817 M | 883 M | 523 M | 520 M | 488 M | 694 M | 765 M | 1.06 B | 1.42 B | 1.03 B | 1.05 B | 234 M | 202 M | 469 M | 767 M | - | 560 M | 378 M | 463 M | 583 M | 436 M | 419 M | 402 M | 519 M | 636 M | 689 M | 742 M | 517 M | 291 M | 146 M | - | - |
Deferred Revenue |
- | 2.39 B | 2.26 B | 108 M | 81 M | 72 M | 87 M | 2.06 B | - | - | 2.98 B | - | 2.61 B | - | 1.16 B | - | 1.06 B | - | - | - | 1.52 B | - | - | 436 M | 419 M | 402 M | 519 M | 636 M | 689 M | 742 M | 371 M | - | - | - | - |
Total Current Liabilities |
25.9 B | 27.5 B | 28.9 B | 15.1 B | 24.6 B | 21.3 B | 26.2 B | 26.3 B | 36.8 B | 27.5 B | 25.1 B | 22.2 B | 27.9 B | 25.6 B | 13.2 B | 16 B | 24 B | 6.66 B | 7.95 B | 13.9 B | 15.8 B | 16.5 B | 15.8 B | 7.98 B | 7.96 B | 7.93 B | 9.68 B | 11.4 B | 12.6 B | 13.7 B | 9.46 B | 5.22 B | 3.93 B | 2.65 B | 2.86 B |
Long-Term Debt |
23.1 B | 22.2 B | 15.4 B | 26.1 B | 35.3 B | 40.2 B | 29.7 B | 25 B | 32.3 B | 28.5 B | 28.4 B | 22.5 B | 17.1 B | 15.2 B | 12.3 B | 8.9 B | 7.75 B | 7.81 B | 6.42 B | 5.35 B | 2.52 B | 2.12 B | 1.57 B | 5.77 B | 5.21 B | 4.65 B | 2.72 B | 799 M | 665 M | 530 M | 2.72 B | 4.91 B | 3.64 B | 2.36 B | 1.28 B |
Deferred Revenue Non Current |
- | - | - | -198 M | -221 M | -225 M | -203 M | - | - | -248 M | -248 M | -270 M | -269 M | -392 M | - | -709 M | -519 M | -57 M | - | -263 M | - | - | - | - | - | - | 0.5 | 1 | 1 | 1 | 0.5 | - | - | - | - |
Deferred Tax Liabilities Non Current |
357 M | 347 M | 165 M | 198 M | 221 M | 225 M | 203 M | 446 M | 347 M | 248 M | 248 M | 270 M | 269 M | 392 M | 420 M | 709 M | 519 M | 57 M | - | 263 M | 207 M | 211 M | 247 M | 193 M | 170 M | 148 M | 143 M | 138 M | 111 M | 83.5 M | 149 M | 214 M | 210 M | 206 M | 218 M |
Total Non Current Liabilities |
23.4 B | 22.5 B | 15.6 B | 26.3 B | 35.6 B | 40.4 B | 30 B | 25.5 B | 32.7 B | 28.8 B | 28.6 B | 22.8 B | 17.4 B | 15.6 B | 12.7 B | 9.61 B | 8.27 B | 7.86 B | 6.57 B | 5.61 B | 2.73 B | 2.33 B | 1.82 B | 5.98 B | 5.42 B | 4.85 B | 2.9 B | 942 M | 790 M | 637 M | 2.88 B | 5.13 B | 3.85 B | 2.56 B | 1.5 B |
Total Liabilities |
49.4 B | 50 B | 44.5 B | 41.4 B | 60.1 B | 61.7 B | 56.2 B | 51.9 B | 69.5 B | 56.2 B | 53.7 B | 45 B | 45.3 B | 41.2 B | 25.9 B | 25.6 B | 32.3 B | 14.5 B | 14.5 B | 19.5 B | 18.6 B | 18.8 B | 17.7 B | 14 B | 13.4 B | 12.8 B | 12.6 B | 12.4 B | 13.4 B | 14.3 B | 12.3 B | 10.3 B | 7.78 B | 5.22 B | 4.36 B |
Retained Earnings |
-56.1 B | -55.9 B | -56.1 B | -56.5 B | -55.2 B | -63.9 B | -61.5 B | -56.4 B | -52.7 B | -34.8 B | -29.7 B | -16.2 B | -16.6 B | -7.21 B | -7.24 B | -5.86 B | -6.98 B | -17.4 B | -16.7 B | -7.59 B | -6.48 B | -6.17 B | -5.5 B | -4.17 B | -3.67 B | -3.17 B | -3.24 B | -3.32 B | -2.35 B | -1.37 B | 175 M | 1.72 B | 1.34 B | 955 M | 838 M |
Accumulated Other Comprehensive Income Loss |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.31 B | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 122 M | 244 M | 122 M | - | - |
Total Stockholders Equity |
-6.64 B | -6.43 B | -6.65 B | -7 B | -5.7 B | -25.9 B | -23.6 B | -18.5 B | -36.8 B | -18.9 B | -13.8 B | 26 M | -531 M | 3.83 B | 1.39 B | 2.7 B | -740 M | -11.1 B | -10.4 B | -890 M | 214 M | 525 M | 1.2 B | 2.16 B | 2.17 B | 2.18 B | 1.22 B | 262 M | 1.06 B | 1.86 B | 2.09 B | 2.33 B | 1.86 B | 1.39 B | 1.27 B |
Total Liabilities And Stockholders Equity |
42.7 B | 43.6 B | 37.8 B | 34.4 B | 54.4 B | 35.8 B | 32.6 B | 33.4 B | 32.7 B | 37.4 B | 39.9 B | 45 B | 44.8 B | 45 B | 27.3 B | 28.7 B | 32.6 B | 3.48 B | 4.21 B | 22.3 B | 22.2 B | 22.7 B | 21.9 B | 18.8 B | 18 B | 17.3 B | 17.3 B | 17.3 B | 18.6 B | 19.9 B | 16.9 B | 13.8 B | 10.4 B | 7.03 B | 5.88 B |
Total Investments |
-680 M | - | - | 496 M | 384 M | 543 M | 945 M | -522 M | -28 M | - | - | - | - | 135 M | 145 M | - | - | -92 M | - | - | 228 M | 545 M | 280 M | - | - | - | - | - | - | - | - | - | - | - | - |
Total Debt |
33.2 B | 32.4 B | 31.3 B | 31.2 B | 49.7 B | 50.5 B | 40.6 B | 38.8 B | 55.2 B | 39.7 B | 32.2 B | 26.5 B | 20.3 B | 15.8 B | 13.2 B | 10.5 B | 12.5 B | 9.61 B | 8.55 B | 12.2 B | 10.9 B | 9.91 B | 9.57 B | 12.7 B | 10.1 B | 7.47 B | 5.97 B | 4.46 B | 5.85 B | 7.24 B | 6.95 B | 6.66 B | 4.91 B | 3.16 B | 2.69 B |
Net Debt |
32.6 B | 31.6 B | 29.6 B | 29.5 B | 48.7 B | 49.3 B | 39.8 B | 38.4 B | 54.7 B | 39 B | 31.5 B | 26.2 B | 19.7 B | 15.5 B | 12.9 B | 9.75 B | 12.1 B | 9.38 B | 8.06 B | 11.4 B | 10.1 B | 9.32 B | 8.68 B | 11.6 B | 9.19 B | 6.74 B | 5.25 B | 3.75 B | 5.09 B | 6.43 B | 6.38 B | 6.32 B | 4.63 B | 2.93 B | 2.56 B |
Alle Zahlen in RUB-Währung
Die Bilanz ist ein grundlegender Finanzbericht von Аптеки 36.6, der ein vollständiges Bild der finanziellen Lage des Unternehmens zu einem bestimmten Zeitpunkt liefert. Im Gegensatz zur Gewinn- und Verlustrechnung, die die Ergebnisse der Geschäftstätigkeit über einen bestimmten Zeitraum festhält, zeigt die Bilanz, welche Vermögenswerte das Unternehmen besitzt, welche Verbindlichkeiten gegenüber Gläubigern bestehen und welches Eigenkapital den Eigentümern zur Verfügung steht.
Für Investoren ist die Bilanz wichtig, da sie die finanzielle Stabilität des Unternehmens beurteilen, die Höhe der Schulden verstehen und erkennen lässt, wie stark das Unternehmen von Fremdfinanzierung abhängig ist. Sie hilft bei der Berechnung wichtiger Liquiditäts- und Verschuldungskennzahlen. Bei der Analyse sollte besonderes Augenmerk auf das Verhältnis von Fremd- zu Eigenkapital (Debt/Equity), die Höhe der liquiden Mittel in der Bilanz und das Verhältnis von kurzfristigen Verbindlichkeiten zu liquiden Aktiva gelegt werden.
Besonderheiten der Bilanzanalyse- Vertikale und horizontale Analyse
Die vertikale Analyse zeigt die Struktur der Bilanz als Prozentsatz der Gesamtaktiva oder -passiva, während die horizontale Analyse die Entwicklung der Kennzahlen über mehrere Perioden darstellt. - Qualität der Vermögenswerte
Es ist wichtig, nicht nur die Höhe der Vermögenswerte, sondern auch deren Liquidität und Verwertbarkeit zu bewerten. - Berücksichtigung außerbilanzieller Verpflichtungen
Einige Verpflichtungen werden möglicherweise nicht direkt in der Bilanz ausgewiesen, was zusätzliche Aufmerksamkeit erfordert.
Bilanz anderer Industrieaktien – Pharmaeinzelhändler
| Name | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|
 |
Greenlane Holdings
GNLN
|
$ 1.57 | -14.67 % | $ 11.8 M |  USA |
 |
China Jo-Jo Drugstores, Inc.
CJJD
|
- | -5.59 % | $ 49.9 M |  China |
 |
BOQI International Medical
BIMI
|
- | 6.33 % | $ 5.86 M | China |
 |
Trxade Group
MEDS
|
- | 4.55 % | $ 5.8 M | USA |
 |
PetMed Express
PETS
|
$ 3.2 | -1.54 % | $ 65.9 M | USA |
 |
111
YI
|
$ 2.53 | -3.8 % | $ 435 M | China |
 |
LifeMD
LFMD
|
$ 3.41 | -2.29 % | $ 116 M | USA |
 |
Rite Aid Corporation
RAD
|
- | - | $ 35.5 M | USA |
 |
Walgreens Boots Alliance
WBA
|
- | - | $ 10.3 B | USA |